UBS has initiated coverage of Sight Sciences (SGHT) with a Buy recommendation, projecting a 44.28% upside based on an average one-year price target of $5.57 per share. The company anticipates a 51.68% increase in annual revenue, reaching $121 million, despite a projected non-GAAP EPS of -1.00. Institutional ownership has risen, with 182 funds reporting positions, although some major shareholders, including UBS and Bank of America, have reduced their stakes significantly.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.